Contact Us
Drug Search Results
More Filters [+]

Barnidipine

Alternative Names: barnidipine
Latest Update: 2022-01-01
Latest Update Note: PubMed Publication

Product Description

Barnidipine is a long-acting novel calcium antagonist that belongs to the dihydropyridine (DHP) group of calcium channel blockers.  (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Barnidipine)

Mechanisms of Action: Calcium Channel Blocker

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Brazil | Chile | Italy | Korea | Netherlands | Peru | Portugal | Spain | Taiwan | Thailand

Approved Indications: None

Known Adverse Events: None

Company: Astellas Pharma
Company Location: NEW YORK NY 10005
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Barnidipine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Hypertension

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
ND

P4

Terminated

Hypertension

2007-11-06

ND

P4

Completed

Hypertension

2007-01-30

2005-004288-47

P4

Active, not recruiting

Hypertension

None

Recent News Events

Date

Type

Title

01/01/2022

PubMed

 Exploring an experimental combination of analytical quality by design and green analytical chemistry approaches for development of HPTLC densitometric protocol for the analysis of barnidipine hydrochloride.

08/01/2021

PubMed

 Computational drug repositioning for ischemic stroke: neuroprotective drug discovery.

01/01/2021

PubMed

 Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions